SAVE MONEY ON TRAVEL DEALS

Study leader Dr. Daniel Hanley of The Johns Hopkins University School of Medicine says tissue plasminogen activator, also known as tPA, can worsen hemorrhaging. However, the researchers in Britain, Canada and German said they were able to use very low doses to dissolve the trapped blood out of the brain in an average of three to four days with minimal additional bleeding.

"We've gone from what's usually an 80 percent death rate in patients with this condition to an 80 percent survival rate", Hanley said in a statement.

The researchers recruited 52 recently diagnosed intracerebral hemorrhage patients in 20 hospitals. Each had a catheter inside the brain to release the trapped blood -- the usual treatment.

Using the same catheter to inject tPA, researchers put each patient on one of three regimens. Progress was tracked with daily CT scans.

Those on 1 milligram of tPA every 8 hours dissolved the clots about a day faster than the other regimens.

After one month, 10 percent of the patients in the study recovered enough to return to their jobs.

The findings were reported at the European Stroke Conference in Nice, France.

 BREAKING STORIES

Study might lead to new AIDS treatment

Weight Watchers compared to going to gym

Scientists create possible footrot vaccine

Multi-target therapy helps lupus patients

Non-toxic nanotherapy for cancer created

DNA vaccination for avian flu created

British dentist signs four-album deal

Study explains how cold sore virus hides

Women may respond less to two heart drugs

Resveratrol seen to boost quality of life

NYC: Most fireworks injuries of children

Diabetic dietary adherence effective

Scientist hones cancer therapy strategies

HIV 5-year death rate has decreased

Menopausal women have trouble sleeping

Father Damien closer to sainthood

Healthy eating in shaky economic times

Study shows green tea heart benefits

British dentists pulling more teeth

More sex may prevent erectile dysfunction